StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
229
This year
8
Publishing Date
2023 - 10 - 27
2
2023 - 09 - 12
3
2023 - 07 - 05
2
2023 - 06 - 26
2
2023 - 04 - 25
2
2023 - 04 - 10
2
2023 - 03 - 16
2
2023 - 03 - 15
2
2023 - 02 - 02
2
2023 - 01 - 30
2
2022 - 11 - 10
2
2022 - 10 - 26
2
2022 - 09 - 15
2
2022 - 08 - 31
2
2022 - 06 - 03
2
2022 - 05 - 18
2
2022 - 05 - 17
2
2022 - 04 - 25
3
2022 - 03 - 02
2
2022 - 01 - 19
2
2021 - 12 - 27
2
2021 - 12 - 09
2
2021 - 12 - 07
3
2021 - 11 - 12
2
2021 - 10 - 27
2
2021 - 10 - 13
2
2021 - 09 - 28
2
2021 - 09 - 02
2
2021 - 08 - 26
2
2021 - 08 - 19
2
2021 - 08 - 11
2
2021 - 08 - 03
2
2021 - 07 - 21
3
2021 - 07 - 20
3
2021 - 06 - 22
2
2021 - 06 - 11
2
2021 - 06 - 04
3
2021 - 05 - 20
2
2021 - 04 - 27
1
2021 - 04 - 26
1
2021 - 04 - 20
1
2021 - 04 - 09
1
2021 - 04 - 05
1
2021 - 03 - 25
1
2021 - 03 - 18
1
2021 - 03 - 17
1
2021 - 03 - 08
1
2021 - 03 - 05
1
2021 - 03 - 02
2
2021 - 03 - 01
1
2021 - 02 - 09
1
2021 - 02 - 08
1
2021 - 01 - 31
1
2021 - 01 - 27
1
2021 - 01 - 26
1
2021 - 01 - 19
2
2021 - 01 - 10
1
2020 - 12 - 30
1
2020 - 12 - 22
1
2020 - 12 - 09
2
Sector
Commercial services
4
Communications
9
Consumer non-durables
1
Finance
10
Finance and insurance
6
Health services
2
Health technology
229
Manufacturing
6
N/a
2
Producer manufacturing
1
Retail trade
1
Technology services
1
Tags
Agreement
6
Antibody
23
Approval
6
Authorized
7
Back
4
Biotech-beach
19
Brazil
6
Cancer
17
Ceo
6
China
4
Clearance
13
Clinical-trials-phase-ii
7
Commercialization
5
Company
10
Conference
14
Covid
35
Covid-19
16
Diagnostic
4
Distribution
4
Drop
6
Drug
11
Drug delivery
4
Enroll
7
Fda
21
Fda clearance
8
Financial
4
Infections
4
License
14
Liver
4
Market
6
Meeting
5
N/a
183
Opioid
5
Order
4
Osteoarthritis
4
Pharmaceuticals
6
Phase 1
10
Phase 1b
6
Phase 2
20
Phase 2b
8
Phase 3
8
Positive
19
Research
8
Results
28
Sars-cov-2
17
Solid tumors
4
Sp-102
4
Sp-103
5
Sti-1558
8
Sti-9167
4
Study
9
T-cell
4
Test
13
Therapeutics
22
Therapy
9
Treatment
37
Trial
33
Vaccine
8
Virpax
5
Ztlido
8
Entities
Agenus inc.
1
Amalgamated bank
5
Amgen inc.
2
Anaptysbio, inc.
1
Anixa biosciences, inc.
1
Autolus therapeutics plc
1
Bed bath & beyond inc.
1
Beigene, ltd.
1
Bellicum pharmaceuticals, inc.
1
Biontech se
1
Bluebird bio, inc.
1
Bnp paribas
5
Bristol-myers squibb company
1
Broadridge financial solutions, inc.
3
Caredx, inc.
1
Cellectis s.a.
1
Centene corporation
2
Cyren ltd.
1
Deutsche bank ag
4
Dyadic international, inc.
3
Dynavax technologies corporation
1
Eli lilly and company
1
Fate therapeutics, inc.
1
Gilead sciences, inc.
4
Glaxosmithkline plc
1
Golden matrix group, inc.
1
Helius medical technologies, inc.
1
Hyrecar inc.
1
I-mab
1
Immunogen, inc.
4
Incyte corporation
1
Johnson & johnson
3
London stock exchange group
1
Medies
1
Moderna, inc.
1
Moelis & company
1
Morgan stanley
6
Mustang bio, inc.
1
Nasdaq, inc.
1
Nordstrom, inc.
1
Novartis ag
2
Nutriband inc.
6
Omeros corporation
1
Oncorus, inc.
1
Oramed pharmaceuticals inc.
3
Orange
9
Pfizer, inc.
3
Physicians realty trust
1
Poseida therapeutics, inc.
1
Precigen, inc.
1
Sanofi
2
Scilex holding company
49
Sorrento therapeutics, inc.
229
Teva pharmaceutical industries limited
2
Therapeuticsmd, inc.
2
U.s. bancorp
4
Ubs ag
4
United therapeutics corporation
2
Virpax pharmaceuticals inc
3
X financial
4
Symbols
ABBV
156
ABEO
115
ADCT
145
AKBA
116
ALDX
123
ALLO
177
AMGN
137
AMRN
134
AQST
147
ATHE
106
AXSM
116
AZN
117
BCLI
131
BMY
131
BTAI
167
CALT
141
FATE
255
FULC
134
GILD
107
GOOG
193
GOOGL
193
GSK
150
GTHX
136
HOTH
109
HZNP
146
JNJ
521
KPTI
166
LCTX
109
LLY
283
MCRB
116
MDNA
108
MOR
186
MPSYF
182
MS
208
NKTR
366
NRIX
147
NTLA
112
NVS
225
NVSEF
191
OCX
178
ONTX
113
OTLK
146
PSTV
123
PSTX
110
PTCT
266
RLFTF
109
RLFTY
109
SNY
705
SNYNF
547
SPRO
121
SRNE
229
SRPT
164
TGTX
148
TVTX
120
TXMD
190
UTHR
142
VTGN
116
VXRT
181
VYNE
172
YMAB
178
Exchanges
Nasdaq
229
Nyse
22
Crawled Date
2023 - 10 - 27
2
2023 - 09 - 12
3
2023 - 07 - 05
2
2023 - 06 - 26
2
2023 - 04 - 26
3
2023 - 04 - 10
2
2023 - 03 - 16
4
2023 - 02 - 13
2
2023 - 02 - 02
2
2023 - 01 - 30
2
2022 - 11 - 10
2
2022 - 10 - 26
2
2022 - 09 - 15
2
2022 - 08 - 31
2
2022 - 06 - 03
2
2022 - 05 - 18
2
2022 - 05 - 17
2
2022 - 04 - 25
3
2022 - 03 - 02
2
2022 - 01 - 19
2
2021 - 12 - 27
2
2021 - 12 - 09
2
2021 - 12 - 07
3
2021 - 11 - 12
2
2021 - 10 - 27
2
2021 - 10 - 13
2
2021 - 09 - 28
2
2021 - 09 - 02
2
2021 - 08 - 26
2
2021 - 08 - 19
2
2021 - 08 - 11
2
2021 - 08 - 03
2
2021 - 07 - 21
3
2021 - 07 - 20
3
2021 - 06 - 22
2
2021 - 06 - 11
2
2021 - 06 - 04
3
2021 - 05 - 25
1
2021 - 05 - 20
2
2021 - 04 - 27
1
2021 - 04 - 26
1
2021 - 04 - 20
1
2021 - 04 - 09
1
2021 - 04 - 05
1
2021 - 03 - 25
1
2021 - 03 - 18
1
2021 - 03 - 17
1
2021 - 03 - 08
1
2021 - 03 - 05
1
2021 - 03 - 02
2
2021 - 03 - 01
1
2021 - 02 - 09
1
2021 - 02 - 08
1
2021 - 01 - 31
1
2021 - 01 - 27
2
2021 - 01 - 19
2
2021 - 01 - 10
1
2020 - 12 - 30
1
2020 - 12 - 23
1
2020 - 12 - 09
2
Crawled Time
00:00
5
00:02
1
00:20
2
01:00
4
01:08
1
02:00
2
03:00
1
04:00
3
04:20
3
06:00
1
07:00
1
08:00
2
10:00
2
11:00
5
12:00
5
12:20
2
13:00
21
13:15
9
13:20
8
13:30
5
14:00
23
14:04
2
14:05
1
14:15
2
14:20
1
14:30
1
15:00
9
15:20
3
15:30
3
16:00
10
17:00
15
18:00
13
19:00
15
20:00
21
20:20
5
21:00
11
21:04
1
22:00
6
23:00
4
Source
nutriband.com
5
spacfeed.com
4
www.biospace.com
45
www.globenewswire.com
151
www.prnewswire.com
24
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
therapeutics
symbols :
Srne
save search
Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend
Published:
2024-03-27
(Crawled : 13:00)
- globenewswire.com
SCLX
|
$0.8812
-2.09%
-2.13%
2.1M
|
|
-40.4%
|
O:
-0.66%
H:
10.33%
C:
7.33%
SRNE
|
$0.024
-8.85%
57K
|
Health Technology
|
122.22%
|
O:
-11.11%
H:
12.5%
C:
0.0%
company
Virpax Pharmaceuticals Reports 2023 Year-End Results
Published:
2024-03-26
(Crawled : 20:00)
- biospace.com/
VRPX
|
$3.86
-4.46%
-4.66%
6K
|
|
-3.31%
|
O:
-0.68%
H:
3.17%
C:
2.65%
SRNE
|
$0.024
-8.85%
57K
|
Health Technology
|
122.22%
|
O:
11.11%
H:
0.0%
C:
-10.0%
virpax
pharmaceuticals
results
Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Previously Announced Term Sheet with Virpax in Respect of Such Release and Settlement
Published:
2024-03-15
(Crawled : 13:00)
- globenewswire.com
SCLX
|
$0.8812
-2.09%
-2.13%
2.1M
|
|
-35.25%
|
O:
0.72%
H:
2.89%
C:
-2.14%
SRNE
|
$0.024
-8.85%
57K
|
Health Technology
|
42.86%
|
O:
-7.14%
H:
46.15%
C:
38.46%
virpax
wholly
pharmaceuticals
agreement
Scilex Holding Company Announces that the Official Committee of Unsecured Creditors of Sorrento Therapeutics, Inc., has Filed a Motion with the U.S. Bankruptcy Court to Extend the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend from March 31, 2024 to September 30, 2024
Published:
2024-03-02
(Crawled : 00:20)
- globenewswire.com
SCLX
|
$0.8812
-2.09%
-2.13%
2.1M
|
|
Email alert
Add to watchlist
SRNE
|
$0.024
-8.85%
57K
|
Health Technology
|
Email alert
Add to watchlist
company
Virpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.
Published:
2024-02-27
(Crawled : 13:30)
- biospace.com/
VRPX
|
$3.86
-4.46%
-4.66%
6K
|
|
982.67%
|
O:
-14.39%
H:
7.35%
C:
-0.24%
SRNE
|
$0.024
-8.85%
57K
|
Health Technology
|
-28.57%
|
O:
7.14%
H:
66.67%
C:
-11.0%
virpax
pharmaceuticals
Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Enters into a Term Sheet with Virpax Pharmaceuticals, Inc. Regarding a Mutual Release and Settlement Agreement
Published:
2024-02-26
(Crawled : 22:00)
- globenewswire.com
SCLX
|
$0.8812
-2.09%
-2.13%
2.1M
|
|
-56.52%
|
O:
1.45%
H:
15.24%
C:
10.0%
SRNE
|
$0.024
-8.85%
57K
|
Health Technology
|
-28.57%
|
O:
7.14%
H:
66.67%
C:
-11.0%
virpax
wholly
pharmaceuticals
agreement
Global CAR T-Cell Therapy Market Analysis Report 2023: Drug type, Indication, Target Antigen, End-user and Region - Forecast to 2030
Published:
2024-01-24
(Crawled : 17:00)
- prnewswire.com
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-8.55%
|
O:
0.39%
H:
0.82%
C:
-0.74%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-12.41%
|
O:
0.22%
H:
0.43%
C:
-0.39%
SRNE
|
$0.024
-8.85%
57K
|
Health Technology
|
-33.33%
|
O:
-63.33%
H:
263.64%
C:
127.27%
GILD
|
$66.77
0.92%
0.91%
11M
|
Health Technology
|
-16.0%
|
O:
0.1%
H:
0.43%
C:
-0.04%
AUTL
|
$4.51
-6.04%
-6.43%
1.4M
|
Health Technology
|
-18.12%
|
O:
-0.91%
H:
11.52%
C:
4.94%
drug
report
t-cell
global
therapy
market
Scilex Holding Company Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2023 Accomplishments and Outlook for 2024
Published:
2024-01-08
(Crawled : 14:00)
- globenewswire.com
SCLX
|
$0.8812
-2.09%
-2.13%
2.1M
|
|
-55.88%
|
O:
3.82%
H:
5.76%
C:
1.04%
SRNE
|
$0.024
-8.85%
57K
|
Health Technology
|
-82.38%
|
O:
-2.03%
H:
3.42%
C:
-1.08%
company
Virpax Pharmaceuticals Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing
Published:
2023-11-17
(Crawled : 17:00)
- biospace.com/
VRPX
|
$3.86
-4.46%
-4.66%
6K
|
|
417.73%
|
O:
6.92%
H:
0.0%
C:
-7.88%
SRNE
|
$0.024
-8.85%
57K
|
Health Technology
|
-61.9%
|
O:
0.0%
H:
14.29%
C:
3.05%
nasdaq
virpax
pharmaceuticals
UPDATE -- Scilex Holding Company Files Emergency Motion in the United States Bankruptcy Court for the Southern District of Texas for Entry of an Order Compelling the Production of Books and Records from certain Brokers, Dealers, Banks and other Nominees Pursuant to Rule 2004 of the Federal Rules of Bankruptcy Procedure
Published:
2023-10-27
(Crawled : 20:00)
- globenewswire.com
SCLX
|
$0.8812
-2.09%
-2.13%
2.1M
|
|
Email alert
Add to watchlist
SRNE
|
$0.024
-8.85%
57K
|
Health Technology
|
Email alert
Add to watchlist
company
update
order
Scilex Holding Company Files Emergency Motion in the United States Bankruptcy Court for the Southern District of Texas for Entry of an Order Compelling the Production of Books and Records from certain Brokers, Dealers, Banks and other Nominees Pursuant to Rule 2004 of the Federal Rules of Bankruptcy Procedure
Published:
2023-10-27
(Crawled : 18:00)
- globenewswire.com
SRNE
|
$0.024
-8.85%
57K
|
Health Technology
|
Email alert
Add to watchlist
SCLX
|
$0.8812
-2.09%
-2.13%
2.1M
|
|
Email alert
Add to watchlist
company
order
Scilex Holding Company Retains Warshaw Burstein, LLP and Christian Attar Law to Investigate Potential Naked Short Selling, Short Positions, Stock Lending Program Activities and Market Manipulation of Its Stock Price
Published:
2023-10-07
(Crawled : 00:20)
- globenewswire.com
SCLX
|
$0.8812
-2.09%
-2.13%
2.1M
|
|
Email alert
Add to watchlist
SRNE
|
$0.024
-8.85%
57K
|
Health Technology
|
Email alert
Add to watchlist
company
program
potential
market
Scilex Holding Company Provides Notice to All Lenders of Short Positions in the Restricted Dividend Shares of Scilex Holding Company
Published:
2023-10-04
(Crawled : 17:00)
- globenewswire.com
SCLX
|
$0.8812
-2.09%
-2.13%
2.1M
|
|
-28.57%
|
O:
-1.59%
H:
14.52%
C:
13.71%
SRNE
|
$0.024
-8.85%
57K
|
Health Technology
|
-78.49%
|
O:
-2.26%
H:
8.8%
C:
1.87%
company
Scilex Holding Company Provides Notice to All Record Holders and Beneficial Owners of Restricted Shares of Scilex Holding Company
Published:
2023-10-03
(Crawled : 13:00)
- globenewswire.com
SCLX
|
$0.8812
-2.09%
-2.13%
2.1M
|
|
-32.33%
|
O:
-0.75%
H:
0.42%
C:
-4.55%
SRNE
|
$0.024
-8.85%
57K
|
Health Technology
|
-78.95%
|
O:
4.21%
H:
0.0%
C:
-6.06%
company
Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding Company
Published:
2023-09-22
(Crawled : 20:00)
- biospace.com/
SCLX
|
$0.8812
-2.09%
-2.13%
2.1M
|
|
-48.57%
|
O:
0.0%
H:
2.86%
C:
-9.71%
SRNE
|
$0.024
-8.85%
57K
|
Health Technology
|
-83.61%
|
O:
-1.64%
H:
12.33%
C:
-0.92%
ORMP
A
|
$2.265
2.96%
2.87%
110K
|
Health Technology
|
-13.69%
|
O:
-3.04%
H:
3.53%
C:
1.96%
company
Scilex Holding Company Announces the Consummation of the Previously Announced Purchase of all of the Scilex Common Shares, Preferred Shares and Warrants Owned by Sorrento Therapeutics, Inc.
Published:
2023-09-21
(Crawled : 20:00)
- globenewswire.com
SCLX
|
$0.8812
-2.09%
-2.13%
2.1M
|
|
-48.57%
|
O:
0.0%
H:
2.86%
C:
-9.71%
SRNE
|
$0.024
-8.85%
57K
|
Health Technology
|
-83.61%
|
O:
-1.64%
H:
12.33%
C:
-0.92%
ORMP
A
|
$2.265
2.96%
2.87%
110K
|
Health Technology
|
-13.69%
|
O:
-3.04%
H:
3.53%
C:
1.96%
company
Scilex Holding Company Announces the Completion of its SP-103 (lidocaine topical system) 5.4%, Triple Strength Formulation of ZTlido®, Phase 2 trial which achieved its objectives to Evaluate the Safety and Efficacy of SP-103 in Subjects with Moderate to Severe Acute Lower Back Pain (LBP)
Published:
2023-09-14
(Crawled : 13:00)
- globenewswire.com
SCLX
|
$0.8812
-2.09%
-2.13%
2.1M
|
|
-59.64%
|
O:
0.9%
H:
2.22%
C:
-0.44%
SRNE
|
$0.024
-8.85%
57K
|
Health Technology
|
-91.34%
|
O:
-0.43%
H:
4.35%
C:
0.0%
sp-103
ztlido
back
trial
Scilex Holding Company Enters into Non-Binding Term Sheets for the Purchase of all of the Scilex Common Shares, Preferred Shares, and Warrants Currently Owned by Sorrento Therapeutics, Inc. and is Declared the New Successful Bidder
Published:
2023-09-13
(Crawled : 13:00)
- globenewswire.com
SCLX
|
$0.8812
-2.09%
-2.13%
2.1M
|
|
-63.11%
|
O:
1.23%
H:
0.0%
C:
-9.72%
SRNE
|
$0.024
-8.85%
57K
|
Health Technology
|
-89.25%
|
O:
-6.99%
H:
39.83%
C:
33.53%
ORMP
A
|
$2.265
2.96%
2.87%
110K
|
Health Technology
|
-25.82%
|
O:
0.65%
H:
0.0%
C:
-6.17%
Scilex Holding Company Presented Oral and Poster Presentations on ZTlido (lidocaine topical system) at the 2023 Annual PAINWeek Conference Held in Las Vegas, NV
Published:
2023-09-12
(Crawled : 13:30)
- globenewswire.com
SCLX
|
$0.8812
-2.09%
-2.13%
2.1M
|
|
-62.66%
|
O:
2.49%
H:
2.83%
C:
-1.21%
SRNE
|
$0.024
-8.85%
57K
|
Health Technology
|
-90.48%
|
O:
-3.62%
H:
7.95%
C:
-8.1%
conference
ztlido
Sorrento Announces Phase 3 Trial Met Primary Endpoint and Key Secondary Endpoint in Mild or Moderate COVID-19 Adult Patients Treated with Ovydso (Olgotrelvir), an Oral Mpro Inhibitor as a Standalone Treatment for COVID-19
Published:
2023-09-12
(Crawled : 13:30)
- globenewswire.com
SRNE
|
$0.024
-8.85%
57K
|
Health Technology
|
-90.48%
|
O:
-3.62%
H:
7.95%
C:
-8.1%
covid-19
treatment
trial
← Previous
1
2
3
4
5
6
7
8
9
10
11
12
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.